<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="46858">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01847027</url>
  </required_header>
  <id_info>
    <org_study_id>2012-162</org_study_id>
    <nct_id>NCT01847027</nct_id>
  </id_info>
  <brief_title>Exercise and NutraStem (NT-020): Effects on Stem Cells</brief_title>
  <official_title>Phase 2 Study of the Effect of a Nutritional Supplement and Exercise on Human Stem Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Texas Health Science Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Texas Health Science Center</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if an investigational supplement called NutraStem® will
      increase the amount of stem cells in human blood at rest and after exercise.  The
      ingredients found in NutraStem® can be found in nutrition or vitamin shops/stores.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Increased stem cell proliferation in active supplement arm</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Markers of oxidative stress</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Adult Stem Cell Proliferation</condition>
  <arm_group>
    <arm_group_label>Active supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NutraStem, 2 tablets daily, Vitamin D3 (2000 IU), BioVin® (40 mg) and the proprietary blend (900mg).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugar pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo is identical in appearance to the NutraStem® supplement and contains the following ingredients in a Vegi Capsule:
MCC200 DICALCIUM PHOSPHATE BROWN LAKE BLEND (SENSIENT # 09127 ) RED DYE DB-088 (COLORCON) MAGNESIUM STEARATE BLUE #1 ALUM LAKE (POWDER)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NutraStem</intervention_name>
    <arm_group_label>Active supplement</arm_group_label>
    <other_name>NT-020</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Sugar pill</arm_group_label>
    <other_name>Sugar pill</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy men and women

          -  Age 50 to 70 years old

          -  Ability to walk on a treadmill for 15 minutes.

        Exclusion Criteria:

          -  Age less than 50 or greater than 70 years of age.

          -  A history of difficult veins/difficulty obtaining blood samples

          -  Unwilling to follow the procedures of the trial

          -  Participated in more than 2 sessions per week of strenuous exercise in the last month

          -  Unable to tolerate the ingredients in NutraStem® or placebo, or have food allergies

          -  Intentionally lost or gained 10 or more pounds of body weight in the last 3 months

          -  Acute illness

          -  Severe co-morbid disease

          -  Use of any prescription or non-prescription products for antioxidant regimen or stem
             cell supplement within the past 4 weeks

          -  Diabetic

          -  Uncontrolled hypertension

          -  Recent cardiovascular event (past 36 months), or a family history of sudden death or
             heart attacks before the age of 55

          -  Body Mass Index (BMI) of less than 20 or greater than 35 m/kg2;

          -  Participated in a clinical trial in the past 4 weeks

          -  Take methadone, insulin, anticoagulants (blood thinners), MAO's or similar
             medications

          -  Anticipate the need for surgery of any type during the entire study;

          -  Plan to donate blood or blood products during the study or for thirty (30) days
             following the study

          -  Active peptic ulcer disease or reliable history of gastrointestinal bleeding within
             the past five (5) years

          -  Recurrent or a history of intestinal disorders that may interfere with the absorption
             of the product

          -  Any disease or condition that in the investigator's opinion compromises the integrity
             of the clinical trial or the safety of the subject
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meharvan Singh, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Texas Health Science Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kim Brown, RN</last_name>
    <phone>817-735-2694</phone>
    <email>kim.brown@unthsc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Meharvan Singh, PhD</last_name>
    <phone>817-735-5429</phone>
    <email>meharvan.singh@unthsc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of North Texas Health Science Center - Center for Biohealth</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Brown, RN</last_name>
      <phone>817-735-2694</phone>
      <email>kim.brown@unthsc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Meharvan Singh, PhD</last_name>
      <phone>817-735-5429</phone>
      <email>meharvan.singh@unthsc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Meharvan Singh, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 26, 2013</lastchanged_date>
  <firstreceived_date>May 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of North Texas Health Science Center</investigator_affiliation>
    <investigator_full_name>Meharvan Singh</investigator_full_name>
    <investigator_title>Chairman and Professor, Department of Pharmacology and Neuroscience</investigator_title>
  </responsible_party>
  <keyword>Healthy</keyword>
  <keyword>Stem cells</keyword>
  <keyword>Aging</keyword>
  <keyword>Increase stem cell replacement</keyword>
  <keyword>decreased stem cell proliferation</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
